PTC Therapeutics (PTCT) Insider Trading & Ownership $68.81 -0.98 (-1.40%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$68.68 -0.13 (-0.19%) As of 05/22/2026 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$49.77M Get PTCT Insider Trade Alerts Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PTCT Insider Buying and Selling by Quarter PTC Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/15/2026Mark Elliott BouldingVPSell2,812$72.18$202,970.16 5/14/2026Matthew B KleinCEOSell12,572$72.95$917,127.40 5/8/2026Mark Elliott BouldingVPSell3,540$78.97$279,553.80 4/21/2026Matthew B KleinCEOSell2,850$70.91$202,093.50 4/6/2026Mark Elliott BouldingVPSell2,265$69.45$157,304.25 4/2/2026Lee Scott GoldenEVPSell829$67.99$56,363.71 4/1/2026Neil Gregory AlmsteadInsiderSell52,003$69.04$3,590,287.12 3/12/2026Matthew B KleinCEOSell2,662$64.08$170,580.96 3/10/2026Stephanie OkeyDirectorSell15,167$70.00$1,061,690.00 3/5/2026Lee Scott GoldenEVPSell10,000$63.38$633,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/5/2026Neil Gregory AlmsteadInsiderSell3,989$63.38$252,822.82 3/5/2026Stephanie OkeyDirectorSell6,333$63.38$401,385.54 2/19/2026Mark Elliott BouldingVPSell3,019$69.48$209,760.12 2/18/2026Christine Marie UtterCAOSell2,494$69.36$172,983.84 2/18/2026Eric PauwelsInsiderSell3,019$69.36$209,397.84 2/18/2026Lee Scott GoldenEVPSell2,484$69.36$172,290.24 2/18/2026Mark Elliott BouldingVPSell3,081$69.36$213,698.16 2/18/2026Matthew B KleinCEOSell7,371$69.36$511,252.56 2/18/2026Neil Gregory AlmsteadInsiderSell3,056$69.36$211,964.16 2/18/2026Neil Gregory AlmsteadInsiderSell65$69.36$4,508.40 2/18/2026Pierre GravierCFOSell2,992$69.36$207,525.12 2/17/2026Mark Elliott BouldingVPSell2,813$69.29$194,912.77 1/12/2026Eric PauwelsInsiderSell1,024$78.70$80,588.80 1/9/2026Eric PauwelsInsiderSell1,722$77.41$133,300.02 1/9/2026Mark Elliott BouldingVPSell2,314$77.93$180,330.02 1/8/2026Christine Marie UtterCAOSell1,034$76.45$79,049.30 1/8/2026Eric PauwelsInsiderSell4,602$76.50$352,053.00 1/8/2026Lee Scott GoldenEVPSell866$76.45$66,205.70 1/8/2026Mark Elliott BouldingVPSell4,033$76.56$308,766.48 1/8/2026Matthew B KleinCEOSell2,514$76.45$192,195.30 1/8/2026Neil Gregory AlmsteadInsiderSell881$76.45$67,352.45 1/8/2026Neil Gregory AlmsteadInsiderSell59$76.45$4,510.55 1/7/2026Christine Marie UtterCAOSell1,235$77.45$95,650.75 1/7/2026Eric PauwelsInsiderSell1,352$77.48$104,752.96 1/7/2026Lee Scott GoldenEVPSell642$77.48$49,742.16 1/7/2026Mark Elliott BouldingVPSell4,879$77.44$377,829.76 1/7/2026Matthew B KleinCEOSell3,016$77.48$233,679.68 1/7/2026Neil Gregory AlmsteadInsiderSell1,026$77.48$79,494.48 1/7/2026Neil Gregory AlmsteadInsiderSell52$77.48$4,028.96 1/6/2026Christine Marie UtterCAOSell1,381$76.95$106,267.95 You cannot escape this reality (Ad)The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.Read Porter Stansberry's full briefing and find out which moves to make now1/6/2026Eric PauwelsInsiderSell1,789$76.95$137,663.55 1/6/2026Lee Scott GoldenEVPSell1,340$76.95$103,113.00 1/6/2026Mark Elliott BouldingVPSell1,739$76.95$133,816.05 1/6/2026Matthew B KleinCEOSell5,149$76.95$396,215.55 1/6/2026Neil Gregory AlmsteadInsiderSell1,279$76.95$98,419.05 1/6/2026Neil Gregory AlmsteadInsiderSell54$76.95$4,155.30 1/6/2026Pierre GravierCFOSell2,139$76.95$164,596.05 1/5/2026Emma ReeveDirectorSell734$76.00$55,784.00 1/5/2026Mark Elliott BouldingVPSell2,266$75.55$171,196.30 1/2/2026Glenn Md Phd Steele JrDirectorSell12,000$76.35$916,200.00 12/30/2025Matthew B KleinCEOSell8,089$76.64$619,940.96 12/19/2025Eric PauwelsInsiderSell20,508$77.26$1,584,448.08 12/18/2025Eric PauwelsInsiderSell3,202$75.06$240,342.12 12/17/2025Eric PauwelsInsiderSell40,290$75.43$3,039,074.70 12/3/2025Emma ReeveDirectorSell733$78.62$57,628.46 12/2/2025Matthew B KleinCEOSell3,428$79.07$271,051.96 11/25/2025Allan Steven JacobsonDirectorSell14,199$83.55$1,186,326.45 11/25/2025Neil Gregory AlmsteadInsiderSell71,928$83.44$6,001,672.32 11/24/2025Allan Steven JacobsonDirectorSell11,801$80.14$945,732.14 11/24/2025Neil Gregory AlmsteadInsiderSell35,572$80.18$2,852,162.96 11/21/2025Emma ReeveDirectorSell10,000$79.50$795,000.00 11/17/2025Mark Elliott BouldingVPSell2,812$75.99$213,683.88 11/12/2025Emma ReeveDirectorSell7,333$74.50$546,308.50 10/30/2025Emma ReeveDirectorSell15,666$69.50$1,088,787.00 10/7/2025Mark Elliott BouldingVPSell3,375$63.43$214,076.25 10/6/2025Mark Elliott BouldingVPSell2,266$65.07$147,448.62 10/3/2025Allan Steven JacobsonDirectorSell12,000$65.00$780,000.00 10/3/2025Emma ReeveDirectorSell25,562$65.96$1,686,069.52 10/3/2025Mark Elliott BouldingVPSell22,655$65.82$1,491,152.10 10/3/2025Neil Gregory AlmsteadInsiderSell55,000$66.05$3,632,750.00 9/12/2025Mark Elliott BouldingVPSell24,585$61.34$1,508,043.90 9/11/2025Emma ReeveDirectorSell15,705$59.50$934,447.50 9/11/2025Mark Elliott BouldingVPSell22,664$61.00$1,382,504.00 9/9/2025David P SouthwellDirectorSell12,000$58.34$700,080.00 9/8/2025Eric PauwelsInsiderSell39,850$56.92$2,268,262.00 8/28/2025Allan Steven JacobsonDirectorSell1,667$50.15$83,600.05 8/28/2025Allan Steven JacobsonDirectorSell1,667$50.15$83,600.05 8/5/2025Matthew B KleinCEOSell10,739$51.74$555,635.86 7/15/2025Pierre GravierCFOSell2,516$49.46$124,441.36 (Data available from 1/1/2013 forward) PTCT Insider Trading Activity - Frequently Asked Questions Who is on PTC Therapeutics' Insider Roster? The list of insiders at PTC Therapeutics includes Alethia Young, Allan Steven Jacobson, Christine Marie Utter, David P Southwell, Emma Reeve, Eric Pauwels, Glenn Md Phd Steele Jr, Jerome B Zeldis, Lee Scott Golden, Mark Elliott Boulding, Matthew B Klein, Michael Schmertzler, Neil Gregory Almstead, Pierre Gravier, and Stephanie Okey. Learn more on insiders at PTCT. What percentage of PTC Therapeutics stock is owned by insiders? 5.50% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings. Which PTC Therapeutics insiders have been selling company stock? The following insiders have sold PTCT shares in the last 24 months: Allan Steven Jacobson ($3,142,628.29), Christine Marie Utter ($1,478,029.68), David P Southwell ($700,080.00), Emma Reeve ($5,164,024.98), Eric Pauwels ($8,291,419.53), Glenn Md Phd Steele Jr ($916,200.00), Jerome B Zeldis ($1,236,000.00), Lee Scott Golden ($1,200,183.86), Mark Elliott Boulding ($12,954,231.72), Matthew B Klein ($4,580,320.33), Neil Gregory Almstead ($20,547,386.67), Pierre Gravier ($632,270.71), and Stephanie Okey ($1,733,075.54). How much insider selling is happening at PTC Therapeutics? Insiders have sold a total of 953,472 PTC Therapeutics shares in the last 24 months for a total of $62,575,851.31 sold. PTC Therapeutics Active InsidersStuart Walter Peltz (Age 65)CEOMatthew B Klein (Age 54)COO9 recent tradesEmily Luisa Hill (Age 45)CFOAlethia YoungChief Financial Officer, Bicycle TherapeuticsPierre GravierCFO2 recent tradesChristine Marie Utter (Age 47)CAO4 recent tradesDawn SvoronosDirectorStephanie OkeyDirector2 recent tradesAllan Steven Jacobson (Age 80)Director1 recent tradesDavid P SouthwellDirectorEmma ReeveDirector2 recent tradesJerome B ZeldisDirectorMichael SchmertzlerDirectorLee Scott GoldenChief Medical Officer6 recent tradesMark Elliott Boulding (Age 65)VP11 recent tradesEric Pauwels (Age 65)Insider9 recent tradesNeil Gregory Almstead (Age 58)Insider11 recent trades More Insider Trading Tools from MarketBeat Related Companies BNTX Insider Selling INSM Insider Selling MRNA Insider Selling ROIV Insider Selling VTRS Insider Selling GMAB Insider Selling ASND Insider Selling SMMT Insider Selling BBIO Insider Selling ELAN Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:PTCT) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PTC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
